Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA08020197 Palmitoyl Serinol N-(1,3-dihydroxypropan-2-yl)hexadecanamide NA 19:0;O2 C19H39NO3 329.292994
LMFA08020198 Pantothenol (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide NA 9:0;O3 C9H19NO4 205.131409
LMFA08020198 Pantothenol (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide NA 9:0;O3 C9H19NO4 205.131409
LMFA08020199 phenyl [1-(N-succinylamino)pentyl]phosphonate 4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid C15H22NO6P 343.118475
LMFA08020199 phenyl [1-(N-succinylamino)pentyl]phosphonate 4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid C15H22NO6P 343.118475
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020202 S-Acetyldihydrolipoamide-E 8-(acetylsulfanyl)-6-sulfanyloctanamide C10H19NO2S2 249.085720
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08010014 (R)-dihydrolipoamide (6R)-6,8-disulfanyloctanamide C8H17NOS2 207.075155
LMFA08010015 12-amino-dodecanoicacid 12-aminolauramide C12H26N2O 214.204513
LMFA08010016 acetoacetamide 3-oxobutanamide C4H7NO2 101.047679
LMFA08010016 acetoacetamide 3-oxobutanamide C4H7NO2 101.047679
LMFA08010019 Dihydrolipoamide 6,8-disulfanyloctanimidic acid C8H17NOS2 207.075155
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010023 S-Acetyldihydrolipoamide 6-(acetylsulfanyl)-8-sulfanyloctanamide C10H19NO2S2 249.085720
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA08010025 S-aminomethyldihydrolipoamide 8-[(aminomethyl)sulfanyl]-6-sulfanyloctanamide C9H20N2OS2 236.101704
LMFA07070010 (11Z)-eicoseneoylcarnitine 3-[(11Z)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:1 C27H51NO4 453.381810
LMFA07070011 (11Z,14Z)-eicosadienoylcarnitine 3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:2 C27H49NO4 451.366160
LMFA07070012 (13Z,16Z)-docosadienoylcarnitine 3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:2 C29H53NO4 479.397460
LMFA07070013 (2E)-hexenedioylcarnitine 3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 6:2;O2 C13H21NO6 287.136889
LMFA07070014 (2E)-octenoylcarnitine 3-[(2E)-oct-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 8:1 C15H27NO4 285.194009
LMFA07070015 (2E,4Z)-decadienoylcarnitine 3-[(2E,4Z)-deca-2,4-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:2 C17H29NO4 311.209659
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070017 (4Z)-decenoylcarnitine 3-[(4Z)-dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:1 C17H31NO4 313.225309
LMFA07070018 (5Z)-13-carboxytridec-5-enoylcarnitine 3-{[(5Z)-13-carboxytridec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:2;O2 C21H37NO6 399.262089
LMFA07070019 (5Z,8Z)-3-hydroxytetradecadienoylcarnitine 3-{[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:2;O C21H37NO5 383.267174
LMFA07070019 (5Z,8Z)-3-hydroxytetradecadienoylcarnitine 3-{[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:2;O C21H37NO5 383.267174
LMFA07070020 (5Z,8Z)-tetradecadienoylcarnitine 3-[(5Z,8Z)-tetradeca-5,8-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070021 (7Z,10Z)-hexadecadienoylcarnitine 3-[(7Z,10Z)-hexadeca-7,10-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070022 (7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine 3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:4 C29H49NO4 475.366160